Influences of activity wheel access on the body temperature response to MDMA and methamphetamine

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 3, 2011, Pages 295-300

  Gilpin, N W ^a   Wright Jr , M J ^a   Dickinson, G ^a   Vandewater, S A ^a   Price, J U ^a   Taffe, M A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ecstasy; Hyperthermia; Locomotor; Stimulant; Thermoregulation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; HUMAN; HYPERTHERMIA; HYPOTHESIS; LOCOMOTION; MALE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; RISK ASSESSMENT;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 79957652007     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.05.006     Document Type: Article

References (51)

1. Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998;282:298-300. (Pubitemid 28487203)
2. Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J. Chemical analysis of ecstasy pills. JAMA 2000;284:2190.
3. Bankson MG, Cunningham KA. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 2002;26:40-52.
4. Baumann MH, Clark RD, Rothman RB. Locomotor stimulation produced by 3,4-methylene-dioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 2008;90:208-17.
5. Bradbury AJ, Costall B, Naylor RJ, Onaivi ES. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology (Berl) 1987;93:457-65. (Pubitemid 18049584)
6. Brown PL, Kiyatkin EA. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions. Eur J Neurosci 2004;20:51-8. (Pubitemid 38932126)
7. Carvalho M, Carvalho F, Remiao F, de Lourdes Pereira M, Pires-das-Neves R, de Lourdes Bastos M. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 2002;76:166-72. (Pubitemid 34328051)
8. Clark JD, Baldwin RL, Bayne KA, Brown MJ, Gebhart GF, Gonder JC, et al. Guide for the care and use of laboratory animals. Washington D.C.: Institute of Laboratory Animal Resources, National Research Council; 1996. p. 125.
9. Cosgrove KP, Hunter RG, Carroll ME. Wheel-running attenuates intravenous cocaine self-administration in rats: sex differences. Pharmacol Biochem Behav 2002;73:663-71. (Pubitemid 34876718)
10. Crean RD, Davis SA, Taffe MA. Oral administration of (+/-)3,4- methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. Pharmacol Biochem Behav 2007;87(1):11-9.
11. Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience 2006;142:515-25.
12. Dafters RI. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berl) 1994;114:505-8. (Pubitemid 24153501)
13. DamsR, De Letter EA,Mortier KA, Cordonnier JA, LambertWE, PietteMH, et al. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study. J Anal Toxicol 2003;27:318-22. (Pubitemid 36877177)
14. Daniela E, Brennan K, Gittings D, Hely L, Schenk S. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 2004;77:745-50. (Pubitemid 38510285)
15. Della Maggiore V, Ralph MR. The effect of amphetamine on locomotion depends on the motor device utilized. The open field vs. the running wheel. Pharmacol Biochem Behav 2000;65:585-90. (Pubitemid 30182500)
16. Eikelboom R, Lattanzio SB. Wheel access duration in rats: II. Day-night and withinsession changes. Behav Neurosci 2003;117:825-32.
17. Evans KR, Vaccarino FJ. Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake. Pharmacol Biochem Behav 1986;25:1149-51. (Pubitemid 17212791)
18. FantegrossiWE, Bauzo RM,Manvich DM,Morales JC, VotawJR, GoodmanMM, et al. Role of dopamine transporters in the behavioral effects of 3,4- methylenedioxymethamphetamine (MDMA) in nonhuman primates. Psychopharmacology (Berl) 2009;205:337-47.
19. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, et al. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) 2003;166:202-11. (Pubitemid 36384765)
20. Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("Ecstasy"). Anesthesiology 2003;99:1132-6.
21. Gillman PK. Ecstasy, serotonin syndrome and the treatment of hyperpyrexia. Med J Aust 1997;167(109):111.
22. Gold LH, Koob GF. Methysergide potentiates the hyperactivity produced by MDMA in rats. Pharmacol Biochem Behav 1988;29:645-8. (Pubitemid 19256832)
23. Gold LH, Koob GF. MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl) 1989;99:352-6. (Pubitemid 19244113)
24. Gold LH, Koob GF, Geyer MA. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4- methylenedioxyamphetamine in rats. J Pharmacol Exp Ther 1988;247:547-55.
25. Greene SL, Dargan PI, O'Connor N, Jones AL, Kerins M. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy"). Am J Emerg Med 2003;21:121-4.
26. Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl) 2005;178:505-13.
27. Hughes RN, Greig AM. Effects of caffeine, methamphetamine and methylphenidate on reactions to novelty and activity in rats. Neuropharmacology 1976;15:673-6.
28. Itoh K, Fukumori R, Suzuki Y. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat. Life Sci 1984;34:827-33. (Pubitemid 14186781)
29. Kuczenski R, Segal DS, Cho AK, Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 1995;15:1308-17.
30. Lattanzio SB, Eikelboom R. Wheel access duration in rats: I. Effects on feeding and running. Behav Neurosci 2003;117:496-504.
31. Levy KB, O'Grady KE, Wish ED, Arria AM. An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Subst Use Misuse 2005;40:1427-41.
32. Libiseller K, Pavlic M, Grubwieser P, Rabl W. Ecstasy - deadly risk even outside rave parties. Forensic Sci Int 2005;153:227-30. (Pubitemid 41219679)
33. Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 1998;18:5086-94. (Pubitemid 28285417)
34. Mallick A, Bodenham AR. MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C. J Accid Emerg Med 1997;14:336-8.
35. Mascola L, Dassey D, Fogleman S, Paulozzi L, Reed CG. Ecstasy overdoses at a NewYear's Eve rave - Los Angeles, California, 2010. MMWR Morb Mortal Wkly Rep 2010;59:677-81.
36. Mills EM, Rusyniak DE, Sprague JE. The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. J Mol Med 2004;82:787-99.
37. Myles BJ, Jarrett LA, Broom SL, Speaker HA, Sabol KE. The effects of methamphetamine on core body temperature in the rat - part 1: chronic treatment and ambient temperature. Psychopharmacology (Berl) 2008;198:301-11.
38. Patel MM, Belson MG, Longwater AB, Olson KR, Miller MA. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J Emerg Med 2005;29:451-4. (Pubitemid 41501576)
39. PedersenNP, BlessingWW. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 2001;21:8648-54.
40. Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia. Synapse 2004;53:214-21. (Pubitemid 39045540)
41. Saadat KS, Elliott JM, Colado MI, Green AR. Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs. Psychopharmacology (Berl) 2004;173:452-3. (Pubitemid 38703822)
42. Sherwin CM. Voluntary wheel running: a review and novel interpretation. Anim Behav 1998;56:11-27. (Pubitemid 28348956)
43. Smith JB, Clark FC. Effects of d-amphetamine, chlorpromazine, and chlordiazepoxide on intercurrent behavior during spaced-responding schedules. J Exp Anal Behav 1975;24:241-8.
44. Sprague JE, Moze P, Caden D, Rusyniak DE, Holmes C, Goldstein DS, et al. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. Crit Care Med 2005;33:1311-6. (Pubitemid 40827383)
45. Squibb RE, Tilson HA. Modified running wheel for continuous recording of locomotor and ingestive-related behaviors. Physiol Behav 1981;26:735-9. (Pubitemid 11088854)
46. Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN. Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. Drug Alcohol Depend 2006;82:276-81.
47. Tanner-Smith EE. Pharmacological content of tablets sold as "ecstasy": results from an online testing service. Drug Alcohol Depend 2006;83:247-54.
48. van Nieuwenhuijzen PS, Li KM, Hunt GE, McGregor IS. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats. Neuropsychobiology 2009;60:195-203.
49. Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA. Impact of ambient temperature on hyperthermia induced by (+/-)3,4- methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology 2007;32:673-81.
50. Walker QD, Williams CN, Jotwani RP, Waller ST, Francis R, Kuhn CM. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. Psychopharmacology (Berl) 2007;189:435-45. (Pubitemid 44791214)
51. Yagi B. Studies in general activity: II. The effect of methamphetamine. Annual of Animal Psychology 1963;13:37-47.